or Try an Advanced Search...

    Technical Analysis for CABA - Cabaletta Bio, Inc.

    Grade Last Price % Change Price Change
    A 15.20 3.40% 0.50
    CABA closed up 3.4 percent on Thursday, September 28, 2023, on 65 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical CABA trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish 3.40%
    Wide Bands Range Expansion 3.40%
    Down 3 Days in a Row Weakness 3.40%
    Down 4 Days in a Row Weakness 3.40%
    Fell Below 20 DMA Bearish 2.29%
    Older End-of-Day Signals for CABA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Rose Above 20 DMA about 9 hours ago
    Possible NR7 about 11 hours ago
    Possible Inside Day about 11 hours ago
    20 DMA Resistance about 13 hours ago
    Up 3% about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CABA Chart by TradingView
    Basic chart:

    Profile

    Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Immunology Antibodies Autoimmune Disease Proprietary Technology Autoimmunity T Cell

    Is CABA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 25 What Makes Cabaletta Bio, Inc. (CABA) a Good Fit for 'Trend Investing'
    Sep 21 Cabaletta Bio director purchases, sells shares in company
    Sep 19 Cabaletta Bio to Participate in Upcoming Investor Conferences in September
    Sep 19 Cabaletta Bio: How Long Can Unique Cell Therapy Developer's Sensational Bull Run Continue?
    Sep 1 Top Growth Stocks for September 2023
    Sep 1 Top Stocks for September 2023
    Aug 31 Wall Street Analysts Believe Cabaletta Bio, Inc. (CABA) Could Rally 41.61%: Here's is How to Trade
    Aug 31 The 7 Most Promising Momentum Stocks to Own Now
    Aug 30 Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
    Aug 25 Lab Notes: Wistar, Coriell researchers identify potential target for gastric cancers treatment
    See more CABA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.34
    52 Week Low 0.637
    Average Volume 633,397
    200-Day Moving Average 11.02
    50-Day Moving Average 13.92
    20-Day Moving Average 15.21
    10-Day Moving Average 15.99
    Average True Range 1.28
    RSI (14) 51.69
    ADX 22.32
    +DI 27.10
    -DI 22.74
    Chandelier Exit (Long, 3 ATRs) 15.49
    Chandelier Exit (Short, 3 ATRs) 16.78
    Upper Bollinger Bands 17.75
    Lower Bollinger Band 12.67
    Percent B (%b) 0.5
    BandWidth 33.43
    MACD Line 0.44
    MACD Signal Line 0.63
    MACD Histogram -0.1863
    Fundamentals Value
    Market Cap 365.64 Million
    Num Shares 24.1 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -16.21
    Price-to-Sales 0.00
    Price-to-Book 3.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 16.36
    Resistance 3 (R3) 16.27 15.78 16.17
    Resistance 2 (R2) 15.78 15.48 15.83 16.10
    Resistance 1 (R1) 15.49 15.30 15.64 15.59 16.04
    Pivot Point 15.01 15.01 15.08 15.05 15.01
    Support 1 (S1) 14.72 14.71 14.86 14.81 14.36
    Support 2 (S2) 14.23 14.53 14.28 14.30
    Support 3 (S3) 13.94 14.23 14.23
    Support 4 (S4) 14.04